Scholarly Index
Eui‐Cheol Shin
Korea Advanced Institute of Science and Technology; 15,322 total citations; 398 total publications; best world rank #27
Korea Advanced Institute of Science and Technology
15,322Total citations
398Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 206 | KR 6 | 98.98 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 345 | KR 4 | 98.75 |
| Hepatitis C virus research | Lifetime | 530 | KR 13 | 98.53 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 907 | KR 20 | 98.13 |
| Long-Term Effects of COVID-19 | Lifetime | 622 | KR 8 | 95.74 |
| interferon and immune responses | Lifetime | 778 | KR 4 | 95.74 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 672 | KR 6 | 94.42 |
| Immune Cell Function and Interaction | 2021-2025 | 37 | KR 1 | 99.21 |
| COVID-19 Clinical Research Studies | 2021-2025 | 152 | KR 2 | 99.13 |
| T-cell and B-cell Immunology | 2021-2025 | 27 | KR 1 | 98.75 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 240 | KR 1 | 98.93 |
| Immunotherapy and Immune Responses | 2021-2025 | 131 | KR 2 | 97.86 |
| Long-Term Effects of COVID-19 | 2021-2025 | 494 | KR 9 | 95.59 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 681 | KR 21 | 97.40 |
| CAR-T cell therapy research | 2021-2025 | 784 | KR 5 | 95.45 |
| vaccines and immunoinformatics approaches | 2021-2025 | 243 | KR 9 | 89.26 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 675 | KR 18 | 78.61 |